Antisense oligonucleotide

Intervention

3 papers3 findings

  • 1 lab in 1 country
  • Funders: Channel 7 Children’s Research Foundation and 5 more
  • 1 of 1 finding with company ties
  • In silico2

Outcomes

2

Chromatin structure

upin silico2

2 studies
  1. Antisense oligonucleotide improves chromatin structure in silico.

    “demonstrating that ASO partially restores chromatin structure in diseased cells.”

    In silicoHutchinson-Gilford Progeria Syndrome and Werner Syndrome; inferred from RNA-seq metricsdiseased cells

    Macroscopic Analyses of RNA-Seq Data to Reveal Chromatin Modifications in Aging and Disease

    eLife23 Sep 2025Preprint

  2. Antisense oligonucleotide improves chromatin structure in silico.

    “demonstrating that ASO partially restores chromatin structure in diseased cells.”

    In silicoHutchinson-Gilford Progeria Syndrome and Werner syndrome; inferred using RNA-seq metricsdiseased cells

    Macroscopic Analyses of RNA-Seq Data to Reveal Chromatin Modifications in Aging and Disease

    eLife23 Sep 2025Preprint

Cellular senescence

upin human cells1

1 study
  1. Antisense oligonucleotide increases cellular senescence in human cells.

    “antisense oligonucleotide-mediated TERRA depletion exacerbates telomere erosion and senescence.”

    Cellsantisense oligonucleotide-mediated TERRA depletionplacenta

    Placentas showed faster molecular aging in late-onset preeclampsia

    Proceedings of the National Academy of Sciences of the United States of America6 Oct 2026

More on Cellular senescence

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months